Tissue Diagnostic Market Market is expected to grow with a CAGR of 6.10% from 2022 to 2028
As stated by our extensive report, providing insights on Type and Applications, the global 3D Printing Ceramic market accounted for 5,157.33 USD Million in 2020.
Tissue Diagnostics is defined as – when all of the tissues are removed for a procedure which is medically indicated that in accordance with appropriate regulatory demands must be sent to the laboratories for reporting, retention, analysis, and ultimately, disposal in a safe manner.
With the rising prevalence of cancer, the Tissue Diagnostic Market Market has witnessed huge demand with profitable growth opportunities in the forecast period. An increase in the adoption of tissue-based diagnostic systems (automated) by the research institutes assists them to perform a swift tumor diagnosis. For instance, in 2019 September, West Clinic Cancer Center partnered with F. Hoffmann-La Roche Ltd. to improve patient care by using Roche’s BenchMark ULTRA Automated Advanced Staining System. This system is used for immunohistochemical testing or in situ hybridization to enable faster diagnosis of tumors.
An increase in the focus of major players to grow advanced tissue-diagnostic centric companion diagnostic tests fuels revenue in the Tissue Diagnostic Market Market. For instance, in April 2019, Agilent received the FDA approval for its PD-L1 IHC 22C3 pharmDx assay designed to identify non-small cell lung cancer. It is a qualitative immunohistochemical assay designed in partnership with Merck.
North America is the largest market. The high prevalence of cancer is one of the key determinants attributives to a significant revenue share of the region. The existence of various public workshops which aim to reduce cancer rate and increase the cancer diagnosis supplements demand in the regional Tissue Diagnostic Market Market. Cancer Prevention and Control Research Network is a program for Disease Control and Prevention by the Centers which focuses on the prevention of cancer in this region. Customized medicine relies greatly on human tissue use for the growth of innovative tests. A rise in the healthcare IT systems and sequencing technologies adoption in the field of clinical workflow has expanded personalized medicine significantly, which also fuels tissue diagnostics usage.
The breast cancer segment held a substantial share in terms of revenue in 2020 due to high occurrence rates of breast cancer across the globe, caused owing to rise in family history and inheritance. Besides, various research initiatives combined with government support and private centers fuel the growth of effective diagnosis products of breast cancer.
Some of the prominent players operating in the Global Tissue Diagnostic Market Market are Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Qiagen (Germany), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), Dipath S.P.A. (Italy)..
Browse the full Report - Tissue Diagnostic Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), by Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining), by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer), by End User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)